Announce Date | 02/26/2024 |
EPS Normalized Actual | $1.17 (Beat by $0.7616) |
EPS GAAP Actual | $1.17 (Beat by $0.7616) |
Revenue Actual | $0.50208B |
Revenue Surprise | Beat by $502.08M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.725 |
EPS GAAP Estimate | $0.725 |
Revenue Estimate | $0.373553B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.99 | 4.24 | 5.99 | 5.99 | 0 |
Dec 2026 | 3.95219 | 6.42 | 3.95219 | 3.95219 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.88 | 0.23833 | 0.50208B | 34.93% | 145.74M |
FQ4 2024 (Dec 2024) | 0.85 | 0.2569 | 0.498819B | 37.3% | 155.74M |
FQ3 2024 (Sep 2024) | 0.76 | 0.1669 | 0.465794B | 37.51% | 122.72M |
FQ2 2024 (Jun 2024) | -2.18 | -2.18 | 0.443594B | 100% | 443.59M |
FQ1 2024 (Mar 2024) | 0.0003 | 0.0003 | 0.326694B | 100% | 326.69M |
FQ4 2012 (Dec 2012) | 0 | 0 | 0.000216B | 100% | 0.22M |
FQ1 2013 (Mar 2013) | 0 | 0 | 0.002909B | 100% | 2.91M |
FQ2 2013 (Jun 2013) | 0 | 0 | 0.002909B | 100% | 2.91M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.725
Consensus Revenue Estimates
0.373553B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.27 | -- | 1.27 | 1.27 | 0 |
FQ3 2026 (Jul 2026) | 1.23 | -- | 1.23 | 1.23 | 0 |
FQ2 2026 (Jun 2026) | 1.23 | -- | 1.23 | 1.23 | 0 |
FQ1 2026 (Mar 2026) | 1.15 | 23.48 | 1.15 | 1.15 | 0 |
FQ4 2025 (Oct 2025) | 0.815 | -4.29 | 0.815 | 0.815 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.48B | -- | 0.48B | 0.48B | 0 |
FQ3 2026 (Jul 2026) | 0.47B | -- | 0.47B | 0.47B | 0 |
FQ2 2026 (Jun 2026) | 0.47B | -- | 0.47B | 0.47B | 0 |
FQ1 2026 (Mar 2026) | 0.45B | -11.57 | 0.45B | 0.45B | 0 |
FQ4 2025 (Oct 2025) | 0.39B | -26.54 | 0.39B | 0.39B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.64167 | 0.88 | 0.23833 | 27.08% |
FQ4 2024 (Dec 2024) | 0.5931 | 0.85 | 0.2569 | 30.22% |
FQ3 2024 (Sep 2024) | 0.5931 | 0.76 | 0.1669 | 21.96% |
FQ2 2024 (Jun 2024) | -2.18 | -2.18 | 100% | |
FQ1 2024 (Mar 2024) | 0.0003 | 0.0003 | 100% | |
FQ4 2012 (Dec 2012) | 0 | 0 | NAN% | |
FQ1 2013 (Mar 2013) | 0 | 0 | NAN% | |
FQ2 2013 (Jun 2013) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.36B | $0.5B | $145.74M | 29.03% |
FQ4 2024 (Dec 2024) | $0.34B | $0.5B | $155.74M | 31.22% |
FQ3 2024 (Sep 2024) | $0.34B | $0.47B | $122.72M | 26.35% |
FQ2 2024 (Jun 2024) | $0B | $0.44B | $443.59M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.33B | $326.69M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0B | $0.22M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0B | $2.91M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0B | $2.91M | 100% |